New active ingredient for anti-aging cosmetics increases hypodermal Collagen I production by up to 325%.

ESLI one is a series of new, patent-protected active ingredients for anti-aging cosmetics. 

ESLI one increases hypodermal Collagen I production by up to 325%, scientifically proven by leading independent skin trial and test laboratory Epistem.

Perceivable benefits associated with increased Collagen I production include improved skin elasticity and hydration for a younger looking appearance.

Unique Opportunity
ESLI ProScience Research is licensing the ESLI one active ingredient for anti-aging products.  Licensing terms are negotiable and ESLI will work with contract partners to develop and maximise product opportunities.

ESLI one’s scientifically-proven performance is expected to offer cosmetics companies significant market advantage.

Test Results
The ESLI one series comprises synergistic combinations of rare plant-derived ingredients proven to strongly induce Collagen I secretion by human dermal fibroblasts.

Synergistic formulations are significantly more effective than the components used individually.

Nine of the ESLI one formulations increase Collagen I expression by over 100%, five by over 150% and one by 325%.

The laboratory trial concluded that “The ability to increase the levels of extracellular collagen in human dermal fibroblast cultures in vitro was confirmed.  There was some variation… but all demonstrated an ability to increase the levels of adhered collagen, relative to vehicle-treated and untreated control cultures.”

All trial samples were screened for cytotoxicity and confirmed non-toxic.

Further Information

ESLI has appointed biotechnology specialists G4 Group as exclusive international marketing agent.

For more information contact the ESLI Product Services Division on 0844 500 2230 or email esli@g4-group.com